{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T01:13:55Z","timestamp":1760145235056,"version":"build-2065373602"},"reference-count":20,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,11,16]],"date-time":"2018-11-16T00:00:00Z","timestamp":1542326400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008497","name":"Boston Scientific Corporation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008497","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004374","name":"Medtronic","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004374","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006279","name":"St. Jude Medical","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006279","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revista Portuguesa de Cardiologia"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1016\/j.repc.2018.01.013","type":"journal-article","created":{"date-parts":[[2018,12,6]],"date-time":"2018-12-06T23:27:43Z","timestamp":1544138863000},"page":"973-978","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Health care cost analysis of enhanced pacing modalities in bradycardia patients: Portuguese case study on the results of the MINERVA trial"],"prefix":"10.1016","volume":"37","author":[{"given":"Jo\u00e3o","family":"de Sousa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pedro","family":"Marques","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V\u00edtor","family":"Martins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ant\u00f3nio","family":"Hip\u00f3lito-Reis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lu\u00eds","family":"Duarte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"In\u00eas","family":"Joaquim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diogo","family":"Monteiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"Boriani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudia","family":"Wolff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Grammatico","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luigi","family":"Padeletti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.repc.2018.01.013_bib0105","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1093\/eurheartj\/ehl176","volume":"27","author":"Fuster","year":"2006","journal-title":"Eur Heart J"},{"key":"10.1016\/j.repc.2018.01.013_bib0110","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.jacc.2014.03.022","article-title":"2014 AHA\/ACC\/HRS guideline for the management of patients with atrial fibrillation","volume":"64","author":"January","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.repc.2018.01.013_bib0115","first-page":"331","article-title":"Preval\u00eancia de fibrilha\u00e7\u00e3o auricular na popula\u00e7\u00e3o portuguesa com 40 ou mais anos. Estudo FAMA","volume":"29","author":"Bonhorst","year":"2010","journal-title":"Rev Port Cardiol"},{"issue":"Supl Especial","key":"10.1016\/j.repc.2018.01.013_bib0120","first-page":"40","article-title":"ESTUDO SAFIRA: preval\u00eancia e padr\u00f5es de tratamento de fibrilha\u00e7\u00e3o auricular e risco cardiovascular em 7500 indiv\u00edduos com 65 ou mais anos","volume":"35","author":"Monteiro","year":"2016","journal-title":"Rev Port Cardiol"},{"key":"10.1016\/j.repc.2018.01.013_bib0125","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1378\/chest.11-2888","article-title":"The global burden of atrial fibrillation and stroke: a systematic review of the epidemiology of atrial fibrillation in regions outside North America and Europe","volume":"142","author":"Lip","year":"2012","journal-title":"Chest"},{"key":"10.1016\/j.repc.2018.01.013_bib0130","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1378\/chest.12-1091","article-title":"Globalization of the epidemiologic, clinical, and financial burden of atrial fibrillation","volume":"142","author":"Boriani","year":"2012","journal-title":"Chest"},{"key":"10.1016\/j.repc.2018.01.013_bib0135","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1093\/eurheartj\/eht491","article-title":"Device-detected atrial fibrillation and risk for stroke: an analysis of >10000 patients from the SOS AF project (Stroke preventiOn Strategies based on Atrial Fibrillation information from implanted devices)","volume":"35","author":"Boriani","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.repc.2018.01.013_bib0140","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1056\/NEJMoa1105575","article-title":"Subclinical atrial fibrillation and the risk of stroke","volume":"366","author":"Healey","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.repc.2018.01.013_bib0145","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1111\/j.1540-8159.2011.03150.x","article-title":"The 11th world survey of cardiac pacing and implantable cardioverter-defibrillators: calendar year 2009 \u2013 a World Society of Arrhythmia's project","volume":"34","author":"Mond","year":"2011","journal-title":"PACE \u2013 Pacing Clin Electrophysiol"},{"key":"10.1016\/j.repc.2018.01.013_bib0150","doi-asserted-by":"crossref","first-page":"2371","DOI":"10.1161\/CIRCULATIONAHA.114.008201","article-title":"Contemporary trends of hospitalization for atrial fibrillation in the United States, 2000 through 2010: implications for healthcare planning","volume":"129","author":"Patel","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.repc.2018.01.013_bib0155","doi-asserted-by":"crossref","first-page":"2516","DOI":"10.1161\/CIRCULATIONAHA.108.821306","article-title":"Atrial fibrillation and heart failure: treatment considerations for a dual epidemic","volume":"119","author":"Anter","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.repc.2018.01.013_bib0160","doi-asserted-by":"crossref","first-page":"2464","DOI":"10.1093\/eurheartj\/eht135","article-title":"Outcomes of apixaban vs. warfarin by type and duration of atrial fibrillation: results from the ARISTOTLE trial","volume":"34","author":"Al-Khatib","year":"2013","journal-title":"Eur Heart J"},{"key":"10.1016\/j.repc.2018.01.013_bib0165","doi-asserted-by":"crossref","first-page":"2352","DOI":"10.1093\/eurheartj\/ehu165","article-title":"Atrial antitachycardia pacing and managed ventricular pacing in bradycardia patients with paroxysmal or persistent atrial tachyarrhythmias: the MINERVA randomized multicentre international trial","volume":"35","author":"Boriani","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.repc.2018.01.013_bib0170","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1016\/j.hrthm.2015.02.017","article-title":"Effects of enhanced pacing modalities on health care resource utilization and costs in bradycardia patients: an analysis of the randomized MINERVA trial","volume":"12","author":"Boriani","year":"2015","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.repc.2018.01.013_bib0175","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.ahj.2008.05.004","article-title":"The MINERVA study design and rationale: a controlled randomized trial to assess the clinical benefit of minimizing ventricular pacing in pacemaker patients with atrial tachyarrhythmias","volume":"156","author":"Funck","year":"2008","journal-title":"Am Heart J"},{"year":"2015","series-title":"Portaria n\u00b0 234\/2015 de 7 de Agosto. Tabela Nacional dos Grupos de Diagn\u00f3stico Homog\u00e9neo","key":"10.1016\/j.repc.2018.01.013_bib0180"},{"year":"2009","series-title":"Base de dados dos elementos anal\u00edticos","author":"ACSS (Autoridade Central do Sistema de Sa\u00fade)","key":"10.1016\/j.repc.2018.01.013_bib0185"},{"year":"1998","series-title":"Orienta\u00e7\u00f5es Metodol\u00f3gicas Para Estudos de Avalia\u00e7\u00e3o Econ\u00f3mica de Medicamentos","author":"Alves da Silva","key":"10.1016\/j.repc.2018.01.013_bib0190"},{"year":"2015","series-title":"The EHRA White Book 2015","author":"Kuck","key":"10.1016\/j.repc.2018.01.013_bib0195"},{"key":"10.1016\/j.repc.2018.01.013_bib0200","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1093\/eurheartj\/eht150","article-title":"2013 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy: the Task Force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC)","volume":"34","author":"Brignole","year":"2013","journal-title":"Eur Heart J"}],"container-title":["Revista Portuguesa de Cardiologia"],"original-title":[],"language":"pt","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0870255117309757?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0870255117309757?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T15:06:44Z","timestamp":1760108804000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0870255117309757"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":20,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["S0870255117309757"],"URL":"https:\/\/doi.org\/10.1016\/j.repc.2018.01.013","relation":{},"ISSN":["0870-2551"],"issn-type":[{"type":"print","value":"0870-2551"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Health care cost analysis of enhanced pacing modalities in bradycardia patients: Portuguese case study on the results of the MINERVA trial","name":"articletitle","label":"Article Title"},{"value":"Revista Portuguesa de Cardiologia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.repc.2018.01.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Sociedade Portuguesa de Cardiologia. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}]}}